UNSPSC 51111860: Mitotane

This classification denotes an anti-adrenal with the molecular formula C14H10Cl4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78E4J5IB5J, chemically known as 2,4-dichlorophenyldichlorethane but generally known as mitotane, which bears US NIH Compound Identifier 4211. European Medicines Agency schedules Mitotane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09010MIG.

UNSPSC 51111860 Mitotane, a Commodity code, encompasses pharmaceutical active ingredients and finished dosage forms that state and local governments procure through cooperative purchasing vehicles and direct supply agreements. Recent activity shows state and local buyers acquiring mitotane and related generic pharmaceuticals through multi-source agreements that consolidate purchasing across participating jurisdictions, with vendors supplying products through authorized pharmaceutical wholesalers and meeting FDA compliance, cGMP certification, and Drug Supply Chain Security Act requirements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body soliciting under this code, using cooperative purchasing to aggregate demand across multiple state and local members.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products, closing March 26, 2026, exemplifies current procurement activity under the code. The solicitation requires vendors to supply identified pharmaceutical products with specific National Drug Codes through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), with awards effective July 1, 2026 and a two-year initial term. Evaluation emphasizes price competitiveness (75 percent weight), followed by administrative compliance, EDI capability, fixed pricing, and fee structure acceptance (5 percent each). Vendors must maintain $5 million in commercial general liability coverage, demonstrate relationships with at least two authorized wholesalers with chargeback systems, and accept performance penalties of $200 to $1,500 per violation for late reporting or missed onboarding timelines. The RFP does not disclose specific budget ranges or set-aside designations. Geographic activity centers on the Upper Midwest and Pacific Northwest, with Minnesota and Oregon named as participating jurisdictions.